1. Home
  2. BLDE vs GNFT Comparison

BLDE vs GNFT Comparison

Compare BLDE & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • GNFT
  • Stock Information
  • Founded
  • BLDE 2014
  • GNFT 1999
  • Country
  • BLDE United States
  • GNFT France
  • Employees
  • BLDE N/A
  • GNFT N/A
  • Industry
  • BLDE Aerospace
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BLDE Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • BLDE Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • BLDE 276.7M
  • GNFT 296.4M
  • IPO Year
  • BLDE N/A
  • GNFT 2019
  • Fundamental
  • Price
  • BLDE $3.16
  • GNFT $4.50
  • Analyst Decision
  • BLDE Buy
  • GNFT Strong Buy
  • Analyst Count
  • BLDE 1
  • GNFT 1
  • Target Price
  • BLDE $6.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • BLDE 626.1K
  • GNFT 6.3K
  • Earning Date
  • BLDE 11-12-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • BLDE N/A
  • GNFT N/A
  • EPS Growth
  • BLDE N/A
  • GNFT N/A
  • EPS
  • BLDE N/A
  • GNFT 0.47
  • Revenue
  • BLDE $241,814,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • BLDE $12.14
  • GNFT $155.44
  • Revenue Next Year
  • BLDE $11.35
  • GNFT N/A
  • P/E Ratio
  • BLDE N/A
  • GNFT $9.31
  • Revenue Growth
  • BLDE 12.04
  • GNFT 175.45
  • 52 Week Low
  • BLDE $2.45
  • GNFT $3.08
  • 52 Week High
  • BLDE $4.25
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 37.44
  • GNFT 28.81
  • Support Level
  • BLDE $3.18
  • GNFT $5.10
  • Resistance Level
  • BLDE $3.76
  • GNFT $5.81
  • Average True Range (ATR)
  • BLDE 0.24
  • GNFT 0.21
  • MACD
  • BLDE -0.06
  • GNFT -0.16
  • Stochastic Oscillator
  • BLDE 5.75
  • GNFT 6.13

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: